{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:20:21Z","timestamp":1770747621524,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3415-1","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T13:36:15Z","timestamp":1497879375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes"],"prefix":"10.1186","volume":"17","author":[{"given":"Ema","family":"Kantorov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Bitt\u0161ansk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0160tefan","family":"Siv\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Baranovi\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Hnilicov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Nos\u00e1\u013e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"\u010cierny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Zele\u0148\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egon","family":"Kur\u010da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"3415_CR1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","volume":"255","author":"H Wiendl","year":"2008","unstructured":"Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol. 2008;255:1449\u201363.","journal-title":"J Neurol"},{"key":"3415_CR2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/jnnp.37.5.598","volume":"37","author":"S Currie","year":"1974","unstructured":"Currie S, Urich H. Concurrence of multiple sclerosis and glioma. J Neurol Neurosurg Psychiatry. 1974;37:598\u2013605.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3415_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00690850","volume":"46","author":"H Kalimo","year":"1979","unstructured":"Kalimo H, Frey H, Raine CS, T\u00f6rm\u00e4 T, R\u00f6ytt\u00e4 M. Late-onset malignant astrocytoma in a case of multiple sclerosis. Clinical, neuropathological, virological, and tissue culture studies. Acta Neuropathol. 1979;46:231\u20134.","journal-title":"Acta Neuropathol"},{"key":"3415_CR4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.0b013e3181c777b7","volume":"74","author":"S Hofer","year":"2010","unstructured":"Hofer S, Linnebank M, Weller M, et al. Cancer risk among patients with multiple sclerosis and their parents. Neurology. 2010;74:614\u20135.","journal-title":"Neurology"},{"key":"3415_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0004-282X2002000300024","volume":"60","author":"LC Werneck","year":"2002","unstructured":"Werneck LC, Scola RH, Arruda WO, Torres LF. Glioma and multiple sclerosis: case report. Arq Neuropsiquiatr. 2002 Jun;60:469\u201374.","journal-title":"Arq Neuropsiquiatr"},{"key":"3415_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fneur.2015.00040","volume":"6","author":"D Plantone","year":"2015","unstructured":"Plantone D, Renna R, Sbardella E, Koudriavtseva T. Concurrence of multiple sclerosis and brain tumors. Front Neurol. 2015;6:40.","journal-title":"Front Neurol"},{"key":"3415_CR7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/1352458511402114","volume":"17","author":"M Hutchinson","year":"2011","unstructured":"Hutchinson M. Safety first, efficacy second in disease modifying therapies. Mult Scler. 2011;17:380\u20131.","journal-title":"Mult Scler"},{"key":"3415_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1352458511435105","volume":"18","author":"PS S\u00f8rensen","year":"2012","unstructured":"S\u00f8rensen PS, Bertolotto A, Edan G, et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler. 2012;18:143\u201352.","journal-title":"Mult Scler"},{"key":"3415_CR9","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012;366:1870\u201380.","journal-title":"N Engl J Med"},{"key":"3415_CR10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","volume":"9","author":"CS Tan","year":"2010","unstructured":"Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9:425\u201337.","journal-title":"Lancet Neurol"},{"key":"3415_CR11","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious disease section. Neurology. 2013;80:1430\u20138.","journal-title":"Neurology"},{"key":"3415_CR12","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1177\/1352458513510224","volume":"19","author":"MP Wattjes","year":"2013","unstructured":"Wattjes MP, Richert ND, Killestein J, et al. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler. 2013;19:1826\u201340.","journal-title":"Mult Scler"},{"key":"3415_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crad.2010.03.001","volume":"65","author":"R Shah","year":"2010","unstructured":"Shah R, Bag AK, Chapman PR, Cure JK. Imaging manifestations of progressive multifocal leucoencephalopathy. Clin Radiol. 2010;65:431\u20139.","journal-title":"Clin Radiol"},{"key":"3415_CR14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2169\/internalmedicine.48.2046","volume":"48","author":"S Yamashita","year":"2009","unstructured":"Yamashita S, Kimura E, Hirano T, Uchino M. Tumefactive multiple sclerosis. Inter Med. 2009;48:1113\u20134.","journal-title":"Inter Med"},{"key":"3415_CR15","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awn098","volume":"131","author":"CF Lucchinetti","year":"2008","unstructured":"Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008;131:1759\u201375.","journal-title":"Brain"},{"key":"3415_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2214\/ajr.182.1.1820195","volume":"182","author":"CA Given","year":"2004","unstructured":"Given CA, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol. 2004;182:195\u20139.","journal-title":"AJR Am J Roentgenol"},{"key":"3415_CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5858\/133.1.101","volume":"133","author":"CH Cunliffe","year":"2009","unstructured":"Cunliffe CH, Fischer I, Monoky D, et al. Intracranial lesions mimicking neoplasms. Arch Pathol Lab Med. 2009;133:101\u201323.","journal-title":"Arch Pathol Lab Med"},{"key":"3415_CR18","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1102\/1470-7330.2009.9003","volume":"9","author":"TAGM Huisman","year":"2009","unstructured":"Huisman TAGM. Tumor-like lesions of the brain. Cancer Imaging. 2009;9:S10\u20133.","journal-title":"Cancer Imaging"},{"key":"3415_CR19","doi-asserted-by":"crossref","first-page":"v149","DOI":"10.1093\/neuonc\/nou264.51","volume":"16","author":"M Lee","year":"2014","unstructured":"Lee M, Walsh K, Rey-Dios R, Anderson M. Progressive multifocal leukoencephalopathy mimicking high grade glioma in an immunocompetent patient: a case report. Neuro Oncology. 2014;16:v149\u201350.","journal-title":"Neuro Oncology"},{"issue":"5","key":"3415_CR20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2","volume":"56","author":"PC Burger","year":"1985","unstructured":"Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer. 1985;56(5):1106\u201311.","journal-title":"Cancer"},{"key":"3415_CR21","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/brain\/aws148","volume":"135","author":"E Kingwell","year":"2012","unstructured":"Kingwell E, Bajdik C, Phillips N, et al. Cancer risk in multiple sclerosis: findings from British Columbia. Canada Brain. 2012;135:2973\u20139.","journal-title":"Canada Brain"},{"key":"3415_CR22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jnnp.2009.175463","volume":"81","author":"AF Fois","year":"2010","unstructured":"Fois AF, Wotton CJ, Yeates D, et al. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies. J Neurol Neurosurg Psychiatry. 2010;81:215\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3415_CR23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/jnnp.2009.195776","volume":"81","author":"AE Handel","year":"2010","unstructured":"Handel AE, Ramagopalan SV. Multiple sclerosis and risk of cancer: a meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81:1413\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3415_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","volume":"83","author":"F Catala-Lopez","year":"2014","unstructured":"Catala-Lopez F, Suarez-Pinilla M, Suarez-Pinilla P, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014;83:89\u2013105.","journal-title":"Psychother Psychosom"},{"key":"3415_CR25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/neuonc\/not070","volume":"15","author":"K Hemminki","year":"2013","unstructured":"Hemminki K, Liu X, F\u00f6rsti A, Ji J, Sundquist J, Sundquist K. Subsequent brain tumors in patients with autoimmune disease. Neuro-Oncology. 2013;15:1142\u201350.","journal-title":"Neuro-Oncology"},{"key":"3415_CR26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1148\/radiol.2512072071","volume":"251","author":"DS Kim","year":"2009","unstructured":"Kim DS, Na DG, Kim KH, Kim J, Kim E, Yun BL, et al. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR inaging. Radiology. 2009;251:467\u201375.","journal-title":"Radiology"},{"key":"3415_CR27","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0b013e31823b9b27","volume":"77","author":"J Kuhle","year":"2011","unstructured":"Kuhle J, Gosert R, B\u00fchler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS. Neurology. 2011;77:2010\u20136.","journal-title":"Neurology"},{"key":"3415_CR28","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.3174\/ajnr.A2160","volume":"31","author":"V Cuvinciuc","year":"2010","unstructured":"Cuvinciuc V, Martin-Blondel G, Marchou B. Bonneville F proton MR spectroscopy of progressive multifocal leukoencephalopathy\u2013immune reconstitution inflammatory syndrome. Am J Neuroradiol. 2010;31:E69\u201370.","journal-title":"Am J Neuroradiol"},{"key":"3415_CR29","unstructured":"Cianfoni AS, Niku SG. Imbesi SG. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. Am J Neuroradiol 2007; 28:272\u2013277."},{"key":"3415_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/nbm.822","volume":"16","author":"FA Howe","year":"2003","unstructured":"Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003;16:123\u201331.","journal-title":"NMR Biomed"},{"key":"3415_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ana.410440222","volume":"44","author":"N Stefano De","year":"1998","unstructured":"De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol. 1998;44:273\u20138.","journal-title":"Ann Neurol"},{"key":"3415_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00259-001-0690-4","volume":"29","author":"J-K Chung","year":"2002","unstructured":"Chung J-K, Kim Y, Kim S, et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imagine. 2002;29:176\u201382.","journal-title":"Eur J Nucl Med Mol Imagine"},{"key":"3415_CR33","first-page":"10","volume":"12","author":"D Horakova","year":"2012","unstructured":"Horakova D, Kalincik T. Blahova-Dusankova et al. Clinical correlates of grey matter pathology in multiple sclerosis BMC Neurology. 2012;12:10.","journal-title":"Clinical correlates of grey matter pathology in multiple sclerosis BMC Neurology"},{"key":"3415_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21640","volume":"65","author":"HL Weiner","year":"2009","unstructured":"Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol. 2009;65:239\u201348.","journal-title":"Ann Neurol"},{"key":"3415_CR35","first-page":"1","volume":"116","author":"J Kmiecik","year":"2013","unstructured":"Kmiecik J, Zimmer J. Chekenya M. Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours J Neuro-Oncol. 2013;116:1\u20139.","journal-title":"Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours J Neuro-Oncol"},{"key":"3415_CR36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s10875-012-9686-z","volume":"32","author":"H Okada","year":"2012","unstructured":"Okada H, Khoury SJ. Type17 T-cells in central nervous system autoimmunity and tumors. J Clin Immunol. 2012;32:802\u20138.","journal-title":"J Clin Immunol"},{"key":"3415_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2013.08.013","volume":"264","author":"J Kmiecik","year":"2013","unstructured":"Kmiecik J, Poli A, Brons NH, Waha A, Eide GE, Enger P\u00d8, et al. Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J Neuroimmun. 2013;264:71\u201383.","journal-title":"J Neuroimmun"},{"key":"3415_CR38","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/intimm\/11.8.1337","volume":"11","author":"G Perrin","year":"1999","unstructured":"Perrin G, Schnuriger V, Quiquerez AL, Saas P, Pannetier C, de Tribolet N, et al. Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int Immunol. 1999;11:1337\u201350.","journal-title":"Int Immunol"},{"key":"3415_CR39","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4049\/jimmunol.132.3.1208","volume":"132","author":"LH Elliott","year":"1984","unstructured":"Elliott LH, Brooks WH, Roszman TL. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J Immunol. 1984;132:1208\u201315.","journal-title":"J Immunol"},{"key":"3415_CR40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.132.4.1837","volume":"132","author":"A Fontana","year":"1984","unstructured":"Fontana A, Hengartner H, de Tribolet N, Weber E. Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol. 1984;132:1837\u201344.","journal-title":"J Immunol"},{"key":"3415_CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1158\/1535-7163.MCT-09-0734","volume":"9","author":"J Wei","year":"2010","unstructured":"Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, et al. Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther. 2010;9:67\u201378.","journal-title":"Mol Cancer Ther"},{"issue":"108","key":"3415_CR42","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1073\/pnas.1016030108","volume":"15","author":"Y Soda","year":"2011","unstructured":"Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A. 2011;15(108):4274\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3415_CR43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, di Tomaso E, Duda DG, et al. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8:610\u201322.","journal-title":"Nat Rev Neurosci"},{"key":"3415_CR44","doi-asserted-by":"crossref","unstructured":"Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, et al. A homing mechanism for bone marrow\u2013derived progenitor cell recruitment to the neovasculature. J Clin Invest. 2006;116:652\u201362.","DOI":"10.1172\/JCI24751"},{"key":"3415_CR45","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S. Vimentin as a potential molecular target in cancer therapy or Vimentin, an overview and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68:3033\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"3415_CR46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jnen\/63.5.499","volume":"63","author":"KL Ligon","year":"2004","unstructured":"Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, et al. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol. 2004;63:499\u2013509.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3415_CR47","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrn2936","volume":"11","author":"EM Schwab","year":"2010","unstructured":"Schwab EM. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci. 2010;11:799\u2013811.","journal-title":"Nat Rev Neurosci"},{"key":"3415_CR48","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0360-3016(01)02720-1","volume":"52","author":"BJ Fisher","year":"2002","unstructured":"Fisher BJ, Naumova E, Leighton CC, Naumov GN, Kerklviet N, Fortin D, et al. Ki-67: a prognostic factor for low-grade glioma? Int J Radiat Oncol Biol Phys. 2002;52:996\u20131001.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3415_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-012-0888-2","volume":"109","author":"A Khalil","year":"2012","unstructured":"Khalil A, Serracino H, Damek DM, Ney D, Lillehei KO, Kleinschmidt-DeMasters BK. Genetic characterization of gliomas arising in patients with multiple sclerosis. J Neuro-Oncol. 2012;109:261\u201372.","journal-title":"J Neuro-Oncol"},{"key":"3415_CR50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","volume":"354","author":"RA Rudick","year":"2006","unstructured":"Rudick RA, Stuart WH, Calabresi PA, et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med. 2006;354:911\u201323.","journal-title":"N Engl J Med"},{"key":"3415_CR51","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/jnnp-2013-306936","volume":"85","author":"H Butzkueven","year":"2014","unstructured":"Butzkueven H, Kappos L, Pellegrini F, Trojano M, Wiendl H, Patel RN, et al. Belachew S; TYSABRI observational program (TOP) investigators. Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results. J Neurol Neurosurg Psychiatry. 2014;85:1190\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3415_CR52","unstructured":"International Multiple Sclerosis Genetics Consortium., Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007 Aug 30;357:851\u201362."},{"key":"3415_CR53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1010612327647","volume":"52","author":"HK Machulla","year":"2001","unstructured":"Machulla HK, Steinborn F, Schaaf A, Heidecke V, Rainov NG. Brain glioma and human leukocyte antigens (HLA)-is there an association? J Neuro-Oncol. 2001;52:253\u201361.","journal-title":"J Neuro-Oncol"},{"key":"3415_CR54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-009-9804-9","volume":"94","author":"G Frisullo","year":"2009","unstructured":"Frisullo G, Patanella AK, Nociti V, Cianfoni A, Iorio R, Bianco A, et al. Glioblastoma in multiple sclerosis: a case report. J Neuro-Oncol. 2009;94:141\u20134.","journal-title":"J Neuro-Oncol"},{"key":"3415_CR55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-011-0900-5","volume":"123","author":"I Metz","year":"2012","unstructured":"Metz I, Radue E-W, Oterino A, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol. 2012;123:235\u201345.","journal-title":"Acta Neuropathol"},{"key":"3415_CR56","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00415-011-5929-9","volume":"258","author":"C Lebrun","year":"2011","unstructured":"Lebrun C, Vermersch P, Brassat D, et al. Cancer and multiple sclerosis in the era of disease-modifying treatments. J Neurol. 2011;258:1304\u201311.","journal-title":"J Neurol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3415-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T21:05:34Z","timestamp":1719263134000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3415-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3415"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3415-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]},"article-number":"424"}}